Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

Chest

Volumn 108, Issue 4 SUPPL., 1995, Pages 371S-379S

  Stein, P D ^a   Alpert, J S ^a   Copeland, J ^a   Dalen, J E ^a   Goldman, S ^a   Turpie, A G G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DIPYRIDAMOLE;

ANTICOAGULATION; BIOPROSTHESIS; BLEEDING; CONFERENCE PAPER; DRUG EFFICACY; HEART VALVE PROSTHESIS; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 0028876997     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.108.4_Supplement.371S     Document Type: Conference Paper

References (59)

1. Stein PD Alpert JS Copeland J Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 102 suppl 1992 445S 455S
2. Horstkotte D Schulte HD Bircks W Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical Prosthesis J Thorac Cardiovasc Surg 107 1994 1136 1145
3. Stein PD Grandison D Hua TA Therapeutic levels of oral anticoagulation with warfarin in patients with mechanical prosthetic heart valves: review of literature and recommendations based on international normalized ratio Postgrad Med J 70 suppl l 1994 S72 83
4. Wilson DB Dunn MI Hassanein K. Low-intensity anticoagulation in mechanical cardiac prosthetic valves Chest 100 1991 1553 1557
5. Baudet EM Oca CC Roques XF A 5½ year experience with the St. Jude Medical cardiac valve prosthesis: early and late results of 737 valve replacements in 671 patients J Thorac Cardiovasc Surg 90 1985 137 144
6. Vogt S Hoffmann A Roth J Heart valve replacement with the Bjork-Shiley and St. Jude Medical prostheses: a randomized comparison in 178 patients Eur Heart J 11 1990 583 591
7. Kopf GS Hammond GL Geha AS Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin Circulation 76 suppl 3 1987 III-132-36
8. Saour JN Sieck JO Mamo LAR Trial of different intensities of anticoagulation in patients with prosthetic heart valves N Engl J Med 322 1990 428 432
9. Bjork VO Henze A. Management of thrombo-embolism after aortic valve replacement with the Bjork-Shiley tilting disc valve: medicamental prevention with dicumarol in comparison with dipyridamole-acetylsalicylic acid: surgical treatment of prosthetic thrombosis Scand J Thorac Cardiovasc Surg 9 1975 183 191
10. Bloomfield P Wheatley DJ Prescott RJ Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses N Engl J Med 324 1991 573 579
11. Sethia B Turner MA Lewis S Fourteen years' experience with the Bjork-Shiley tilting disc prosthesis J Thorac Cardiovasc Surg 91 1986 350 361
12. Vallejo JL Gonzalez-Santos JM Albertos J Eight years' experience with the Medtronic-Hall valve prosthesis Ann Thorac Surg 50 1990 429 436
13. Butchart EG Lewis PA Grunkemeier GL Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation Circulation 78 suppl 1 1988 I66 I77
14. Van der Meer FJM Rosendaal FR Vandenbroucke JP Bleeding complications in oral anticoagulant therapy: an analysis of risk factors Arch Intern Med 153 1993 1557 1562
15. Pengo V Garelli E Banzato A Trial evaluating hemorrhagic events at different intensities of oral anticoagulant treatment in patients with mechanical prosthetic heart valves [abstract] Thromb Haemost 69 1993 676
16. Gossinger H Neissner H Grubeck B Thromboembolism in patients with prosthetic heart valves: an adequately controlled intense anticoagulant therapy and its influence on the occurrence of thromboembolism in relation to valve type Thorac Cardiovasc Surg 34 1986 283 286
17. Turpie AGG Gent M Laupacis A Comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement New Engl J Med 329 1993 524 529
18. Cannegieter SC Rosendaal FR Wintzen AR Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 333 1995 11 17
19. Rajah SM Sreeharan N Joseph A Prospective trial of dipyridamole and warfarin in heart valve patients [abstract] Acta Thera (Brussels) 6 1980 54
20. Skudicky D Wisenbaugh T Essop MR Is a very low level of anticoagulation adequate for patients with St. Jude medical prosthesis [abstract]? J Am Coll Cardiol 21 suppl A 1993 415
21. Altman R Rouvier J Gurfinkel E Comparison of two levels of anticoagulant therapy in patients with substitute heart valves J Thorac Cardiovasc Surg 101 1991 427 431
22. Albertal J Sutton M Pereyra D Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement: a retrospective, nonrandomized study J Heart Valve Dis 2 1993 302 307
23. Hartz RS LoCicero J III Kucich V Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude medical valve in the aortic position J Thorac Cardiovasc Surg 92 1986 684 690
24. Yamak B Karagoz HY Zorlutuna Y Low-dose anticoagulant management of patients with St. Jude medical mechanical valve prostheses Thorac Cardiovasc Surg 41 1993 38 42
25. Sutton M Pereyra D Segura EV Effectiveness and safety of moderate regime of anticoagulation with acenocoumarol plus low dose aspirin therapy after mechanical valve replacement: a non-randomized trial [abstract] Eur Heart J 13 suppl 1992 140
26. Fiore L Brophy M Deykin D The efficacy and safety of the addition of aspirin in patients treated with oral anticoagulants after heart valve replacement: a meta-analysis [abstract] Blood 82 suppl 1 1993 409 a
27. Cannegeiter SC Rosendaal FR Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
28. Sullivan JM Harken DE Gorlin R. Effect of dipyridamole on the incidence of arterial emboli after cardiac valve replacement Circulation 39-40 suppl l 1969 I-149-53
29. Groupe de recherche P.A.C.T.E. Prevention des accidents thrombo-emboliques systemiques chez les porteurs de protheses valvulaires artificielles. Coeur 1978; 9:915-69
30. Chesebro JH Fuster V Elveback LR Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole Am J Cardiol 51 1983 1537 1541
31. Ribeiro PA Al Zaibag MA Idris M Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude medical aortic prosthesis in patients with rheumatic heart disease J Thorac Cardiovasc Surg 91 1986 92 98
32. Serra AJS McNicholas KW Olivier HG Jr The choice of anticoagulation in pediatric patients with the St. Jude medical valve prostheses J Cardiovasc Surg 28 1987 588 591
33. Cortelazzo S Finazzi G Viero P Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic Thromb Haemost 69 1993 316 320
34. Tinker JH Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses JAMA 239 1978 738 739
35. Grady RF. Noncardiac surgery in the elderly patient with heart disease Mt Sinai J Med 52 1985 634 642
36. Chesebro JH Adams PC Fuster V. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves J Am Coll Cardiol 8 suppl 1986 41B 56B
37. Bodnar AG Hutter AM. Anticoagulation in valvular heart disease preoperatively and postoperatively Cardiovasc Clin 14 1984 247 264
38. Katholi RE Nolan SP McGuire LB. Living with prosthetic heart valves: subsequent noncardiac operations and the risk of thromboembolism or hemorrhage Am Heart J 92 1976 162 167
39. Rustad H Myhre E. Surgery during anticoagulant treatment Acta Med Scand 173 1963 115 119
40. McIntyre H. Management during dental surgery of patients on anticoagulants Lancet 2 1966 99 100
41. Katholi RE Nolan SP McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves Am Heart J 96 1978 163 165
42. Eckman MH Beshansky JR Durand-Zaleski I Anticoagulation for noncardiac procedures in patients with prosthetic heart valves JAMA 263 1990 1513 1521
43. 1 Thromb Haemost 67 1992 13 15
44. Cohn LH Allred EN DiSesa VJ Early and late risk of aortic valve replacement: a 12-year concomitant comparison of the porcine bioprosthetic and tilting disc prosthetic aortic valves J Thorac Cardiovasc Surg 88 1984 695 705
45. Bolooki H Kaiser GA Malion SM Comparison of long-term results of Carpentier-Edwards and Hancock bioprosthetic valves Ann Thorac Surg 42 1986 494 499
46. Bloomfield P Kitchin AH Wheatley DJ A prospective evaluation of the Bjork-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses Circulation 73 1986 1213 1222
47. Cohn LH Allred EN Cohn LA Early and late risk of mitral valve replacement J Thorac Cardiovasc Surg 90 1985 872 881
48. Louagie YA Jamart J Eucher P Mitral valve Carpentier-Edwards bioprosthetic replacement, thromboembolism, and anticoagulants Ann Thorac Surg 56 1993 931 937
49. Gonzalez-Lavin L Chi S Blair TC Thromboembolism and bleeding after mitral valve replacement with porcine valves: influence of thromboembolic risk factors J Surg Res 36 1984 508 515
50. Nunez L Aguado GM Larrea JL Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis Ann Thorac Surg 37 1984 84 87
51. Williams JB Karp RB Kirklin JW Considerations in selection and management of patients undergoing valve replacement with glutaraldehyde-fixed porcine bioprostheses Ann Thorac Surg 30 1980 247 258
52. Gonzalez-Lavin L Tandon AP Chi S The risk of thromboembolism and hemorrhage following mitral valve replacement J Thorac Cardiovasc Surg 87 1984 340 351
53. Hetzer R Topalidis T Borst HG. Thromboembolism and anticoagulation after isolated mitral valve replacement with porcine heterografts Cohn LH Gallucci V Proceedings, second international symposium on cardiac bioprostheses 1982 Yorke Medical Books New York 170 172
54. Nunez L Aguado GM Celemin D Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis Ann Thorac Surg 33 1982 354 358
55. Oyer PE Stinson EB Griepp RB Valve replacement with the Starr-Edwards and Hancock prostheses: comparative analysis of late morbidity and mortality Ann Surg 186 1977 301 309
56. Ionescu MI Smith DR Hasan SS Clinical durability of the pericardial xenograft valve: 10-years experience with mitral replacement Ann Thorac Surg 34 1982 265 277
57. Magilligan DJ Jr Lewis JW Jr Tilley B The porcine bioprosthetic valve: 12 years later J Thorac Cardiovasc Surg 89 1985 499 507
58. Heras M Chesebro JH Fuster V High risk of early thromboemboli after bioprosthetic cardiac valve replacement J Am Coll Cardiol 25 1995 1111 1119
59. Turpie AGG Gunstensen J Hirsh J Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement Lancet 1 1988 1242 1245